NOSOTRON-4 Ondansetron Mouth Dissolving Tablets IP, 4 mg

Established in 2018, Superlative Health Care is a Famous Manufacturer, Wholesaler And Trader of Ofloxacin Tablet IP and Pantoprazole Domperidone Capsules Range and much more
Superlative Healthcare is a prominent manufacturer and exporter of Non-Beta Lactum tablets and capsules that comply with ISO 9001: 2000 and WHO GMP guidelines. We have produced affordable medicines that have made a profound impact on patient's life worldwide.Superlative Healthcare was established in 2018 as the OTC/Generic Division of Biomax Biotechnics Pvt. Ltd. (BBPL) with its subsidiary unit Healthcorp Pharmachem in Barwala, Haryana. BBPL group is endowed with the services of the most experienced personnel that motivate to carry on the company’s operations and accomplish its ambitious goals of growth and new formulation development. With 400+ product range and a successful history, the BBPL group has dominated the pharmaceutical industry on a global level. Since 2004, Company has PAN India’s presence and exports its best quality products in a few countries.Superlative Healthcare specializes in handling customized business as per the requirements. As a leading company, we have established ourselves as one of India’s best Third- Party Manufacturers in India. From discovery to development to commercialization, our Company’s growth is facilitated by cost-effective, vast pharmaceutical products and deep roots of manufacturing excellence. We focus on the right things and execute them the right way, and we make the best use of our resources and ensure our ability to offer our customers the highest quality.The company’s prospects are quite bright since it has strong management, high-quality control, and a vast manufacturing capacity to produce high-quality products, reducing all hurdles in the company’s growth. The company’s current annual revenue is 80 crores, which will be multiplied in the future. To increase sales in the domestic market, the firm established a new subsidiary, Healthcorp Pharmachem, in January 2021. This new division adheres to WHO GMP standards.